HU9203366D0 - Thrombin and method for producing it - Google Patents

Thrombin and method for producing it

Info

Publication number
HU9203366D0
HU9203366D0 HU9203366A HU9203366A HU9203366D0 HU 9203366 D0 HU9203366 D0 HU 9203366D0 HU 9203366 A HU9203366 A HU 9203366A HU 9203366 A HU9203366 A HU 9203366A HU 9203366 D0 HU9203366 D0 HU 9203366D0
Authority
HU
Hungary
Prior art keywords
thrombin
producing
infectious agents
prothrombin
activation
Prior art date
Application number
HU9203366A
Other languages
Hungarian (hu)
Other versions
HU213867B (en
HUT65390A (en
Inventor
Johann Eibl
Yendra Linnau
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3529491&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HU9203366(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of HU9203366D0 publication Critical patent/HU9203366D0/en
Publication of HUT65390A publication Critical patent/HUT65390A/en
Publication of HU213867B publication Critical patent/HU213867B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Amplifiers (AREA)
  • Revetment (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)

Abstract

The invention relates to a thrombin of human or animal origin, which is free of infectious agents and can be prepared by activation of prothrombin which is subjected to a heat treatment to inactivate infectious agents.
HU9203366A 1991-11-04 1992-10-27 Process for preparing viral-safe thrombin HU213867B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0218391A AT398079B (en) 1991-11-04 1991-11-04 PREPARATION WITH THROMBINE ACTIVITY AND METHOD FOR THEIR PRODUCTION

Publications (3)

Publication Number Publication Date
HU9203366D0 true HU9203366D0 (en) 1993-01-28
HUT65390A HUT65390A (en) 1994-06-28
HU213867B HU213867B (en) 1997-11-28

Family

ID=3529491

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9203366A HU213867B (en) 1991-11-04 1992-10-27 Process for preparing viral-safe thrombin

Country Status (19)

Country Link
US (1) US5714370A (en)
EP (1) EP0541507B1 (en)
JP (1) JP2572513B2 (en)
AT (2) AT398079B (en)
AU (1) AU645715B2 (en)
CA (1) CA2081703C (en)
CZ (1) CZ281502B6 (en)
DE (1) DE59209922D1 (en)
DK (1) DK0541507T3 (en)
ES (1) ES2165355T3 (en)
FI (1) FI104378B (en)
HR (1) HRP921171B1 (en)
HU (1) HU213867B (en)
MX (1) MX9206303A (en)
NO (1) NO312125B1 (en)
PL (1) PL170156B1 (en)
SI (1) SI9200299B (en)
SK (1) SK330992A3 (en)
YU (1) YU96192A (en)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT402891B (en) * 1991-06-20 1997-09-25 Immuno Ag METHOD FOR PRODUCING AN INACTIVATED BLOOD PRODUCT
DE4137996A1 (en) * 1991-11-19 1993-05-27 Behringwerke Ag METHOD FOR PRODUCING A VIRUS-SAFE THROMBINE CONCENTRATE
AT399818B (en) * 1992-04-24 1995-07-25 Immuno Ag METHOD FOR PRODUCING A HIGH PURIFIED VIRUS-SAFE FACTOR VIII PREPARATION
AU6653094A (en) * 1992-12-16 1994-07-04 Immuno Aktiengesellschaft Process for preparing a virus-safe biological composition
DE4320294A1 (en) * 1993-06-18 1994-12-22 Immuno Ag Use of human protein C to prevent and treat platelet deposits
JPH07308190A (en) * 1994-05-18 1995-11-28 Green Cross Corp:The Production of thrombin
US5506127A (en) * 1994-09-21 1996-04-09 Proba; Zbigniew Therapeutic grade thrombin produced by chromatography
GB9503750D0 (en) * 1995-02-24 1995-04-12 Common Services Agency Thrombin preparation
AT404597B (en) 1995-11-24 1998-12-28 Immuno Ag PROCESS FOR PRODUCING PROTEINS
JP3944267B2 (en) * 1996-08-09 2007-07-11 財団法人化学及血清療法研究所 Method for activating prothrombin and method for producing thrombin based on the method
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
AT405608B (en) * 1997-04-08 1999-10-25 Immuno Ag METHOD FOR INACTIVATING PATHOGENS, ESPECIALLY VIRUSES, IN A BIOLOGICAL MATERIAL
AT405485B (en) 1997-05-28 1999-08-25 Immuno Ag A PHARMACEUTICAL PREPARATION CONTAINING THE VWF PROPEPTIDE
WO2001000667A2 (en) * 1999-06-29 2001-01-04 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Anti-thrombin peptide from anopheles albimanus salivary gland
US7795218B2 (en) 2001-04-12 2010-09-14 Bioaxone Therapeutique Inc. ADP-ribosyl transferase fusion variant proteins
GB0216002D0 (en) * 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
WO2007137839A2 (en) * 2006-05-31 2007-12-06 Baxter International Inc. Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
TWI436793B (en) 2006-08-02 2014-05-11 Baxter Int Rapidly acting dry sealant and methods for use and manufacture
EP2214734B1 (en) 2007-10-30 2017-12-13 Baxter International Inc. Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
JP5569398B2 (en) 2008-02-29 2014-08-13 フェッローサン メディカル ディバイス エー／エス Device for promoting hemostasis and / or wound healing
AR081227A1 (en) 2008-12-11 2012-07-18 Baxter Int PREPARATIONS BASED ON SULFATED FIBRINOGENS AND POLISACARIDS
KR101105026B1 (en) * 2009-04-06 2012-01-16 김기영 Multi Reflection Type hand-grinder
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
KR101699992B1 (en) 2009-06-16 2017-01-26 백스터 인터내셔널 인코포레이티드 Hemostatic sponge
AU2010339045B2 (en) 2009-12-16 2014-06-05 Baxter Healthcare S.A. Hemostatic sponge
SA111320355B1 (en) 2010-04-07 2015-01-08 Baxter Heathcare S A Hemostatic sponge
CN103037847B (en) 2010-06-01 2016-01-20 巴克斯特国际公司 For the preparation of the method for dry, stable hemostatic composition
JP6289096B2 (en) 2010-06-01 2018-03-07 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ Process for making a dry and stable hemostatic composition
US8940335B2 (en) 2010-06-01 2015-01-27 Baxter International Inc. Process for making dry and stable hemostatic compositions
CN103957949B (en) 2011-10-11 2017-07-18 巴克斯特国际公司 Hemostatic composition
CN103957948B (en) 2011-10-11 2016-10-26 巴克斯特国际公司 Hemostatic composition
KR101975624B1 (en) 2011-10-27 2019-05-07 백스터 인터내셔널 인코포레이티드 Hemostatic compositions
EP2793934B1 (en) * 2011-12-23 2017-08-23 Merz Pharma GmbH & Co. KGaA Novel method for the manufacturing of di-chain proteins for use in humans
EP2822474B1 (en) 2012-03-06 2018-05-02 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
AU2013275758B2 (en) 2012-06-12 2015-03-12 Ferrosan Medical Devices A/S Dry haemostatic composition
AU2014283170B2 (en) 2013-06-21 2017-11-02 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
JP6489485B2 (en) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ／エス Dry composition containing an extrusion enhancing factor
BR112017007466B1 (en) 2014-10-13 2021-03-02 Ferrosan Medical Devices A/S method for preparing a dry composition, method for reconstituting the dry composition, paste, dry composition, container, homeostatic kit, and, using a dry composition
US10653837B2 (en) 2014-12-24 2020-05-19 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
US10918796B2 (en) 2015-07-03 2021-02-16 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
US20210128778A1 (en) 2017-03-09 2021-05-06 Baxter International Inc. Solvent deposition system and methods
AU2019266529A1 (en) 2018-05-09 2020-12-03 Ethicon Inc. Method for preparing a haemostatic composition

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT350726B (en) * 1976-08-30 1979-06-11 Immuno Ag PROCESS FOR THE PRODUCTION OF A BLOOD CLOTIFYING PREPARATION FROM HUMAN BLOOD PLASMA
DE2902158A1 (en) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh METHOD FOR THE PRODUCTION OF FIBRINOGEN, A PROTHROMINE BIN COMPLEX CONTAINING THE COAGINING FACTORS II, VII, IX AND X, AND ANTITHROMINE III, AND A SOLUTION OF STORAGE-STABLE SERUM PROTEINS
US4357321A (en) * 1980-01-28 1982-11-02 Baxter Travenol Laboratories, Inc. Method and composition for treating clotting factor inhibitors
DE3019612A1 (en) * 1980-05-22 1981-11-26 Boehringer Mannheim Gmbh, 6800 Mannheim STABILIZED THROMBINE PREPARATION
US4404132A (en) * 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
AT368883B (en) * 1980-07-22 1982-11-25 Immuno Ag METHOD FOR PRODUCING A NEW HUMAN PROTEIN-BASED PREPARATION PROCESSING BLOOD
US4480029A (en) * 1981-04-27 1984-10-30 Baxter Travenol Laboratories, Inc. Biological indicators and their use
US4495278A (en) * 1981-04-27 1985-01-22 Baxter Travenol Laboratories, Inc. Process for making novel blood clotting enzyme compositions
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
AT385657B (en) * 1984-03-09 1988-05-10 Immuno Ag METHOD FOR INACTIVATING VARIABLE FILTERABLE DISEASERS IN BLOOD PRODUCTS
AT389815B (en) * 1984-03-09 1990-02-12 Immuno Ag METHOD FOR INACTIVATING VARIABLE FILTERABLE DISEASERS IN BLOOD PRODUCTS
US4613501A (en) * 1984-12-21 1986-09-23 New York Blood Center, Inc. Inactivation of viruses in labile blood derivatives
US4673733A (en) * 1985-04-11 1987-06-16 Sudhish Chandra Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents
JPS63243032A (en) * 1987-03-27 1988-10-07 Green Cross Corp:The Method for heat-treating thrombin
DE3843126C3 (en) * 1988-12-22 1994-10-06 Octapharma Ag Process for the production of a high-purity thrombin concentrate
EP0378208B2 (en) * 1989-01-13 2003-01-15 Mitsubishi Pharma Corporation Production method for protein-containing composition
IE73210B1 (en) * 1990-01-24 1997-05-07 Warner Lambert Co Process for the production of thrombin and high purity thrombin preparation thereby obtained
ES2131504T3 (en) * 1990-02-20 1999-08-01 Baxter Int VIRICALLY SAFE PURIFIED HUMAN THROMBINE.
FR2679251B1 (en) * 1991-07-18 1993-11-12 Nord Assoc Essor Transfusion San PROCESS FOR THE PREPARATION OF A HUMAN THROMBIN CONCENTRATE FOR THERAPEUTIC USE.
DE4137996A1 (en) * 1991-11-19 1993-05-27 Behringwerke Ag METHOD FOR PRODUCING A VIRUS-SAFE THROMBINE CONCENTRATE

Also Published As

Publication number Publication date
AU2736192A (en) 1993-05-06
DE59209922D1 (en) 2001-11-15
FI924975A (en) 1993-05-05
AU645715B2 (en) 1994-01-20
HRP921171A2 (en) 1995-08-31
FI104378B (en) 2000-01-14
CZ330992A3 (en) 1993-06-16
SK279193B6 (en) 1998-07-08
FI924975A0 (en) 1992-11-04
CA2081703C (en) 1999-01-19
HU213867B (en) 1997-11-28
CZ281502B6 (en) 1996-10-16
EP0541507A2 (en) 1993-05-12
MX9206303A (en) 1993-08-01
SI9200299A (en) 1994-06-30
HRP921171B1 (en) 2000-02-29
NO924229D0 (en) 1992-11-03
SK330992A3 (en) 1998-07-08
US5714370A (en) 1998-02-03
AT398079B (en) 1994-09-26
EP0541507B1 (en) 2001-10-10
ATA218391A (en) 1994-01-15
CA2081703A1 (en) 1993-05-05
YU96192A (en) 1995-12-04
JP2572513B2 (en) 1997-01-16
ES2165355T3 (en) 2002-03-16
SI9200299B (en) 2002-02-28
JPH0646852A (en) 1994-02-22
DK0541507T3 (en) 2002-01-28
NO924229L (en) 1993-05-05
PL170156B1 (en) 1996-10-31
HUT65390A (en) 1994-06-28
PL296460A1 (en) 1993-12-13
ATE206757T1 (en) 2001-10-15
NO312125B1 (en) 2002-03-25
EP0541507A3 (en) 1993-06-16

Similar Documents

Publication Publication Date Title
HU9203366D0 (en) Thrombin and method for producing it
NL300433I2 (en) Methods and compositions for the treatment of glomerulonephritis.
SG17493G (en) Ozone decontamination of blood and blood products
DE69603062T2 (en) Food decontamination procedures
DE69232350D1 (en) TREATMENT OF MATERIAL
HU901585D0 (en) Method for treatment of viral infections using functional derivatives of icam-1
DE69429299D1 (en) Use of tachykinin antagonists to treat vomiting
DE69110713T2 (en) 7-Oxabicycloheptan-imidazole prostaglandin analogs, useful in the treatment of thrombotic and vasospastic diseases.
NO961550D0 (en) Method and Preparation for Increasing Biocidal Activity
PL330423A1 (en) Floor lining
ES2072975T3 (en) MIXTURE OF STERILIZER AND STERILIZATION METHOD.
EP0744027A4 (en) Hydrophilic signal oligopeptides and methods of therapeutic use
FI944563A (en) Microorganisms, method of preparation and use
FI903143A0 (en) Method for serotyping human rhinitis virus
DE59010230D1 (en) Method of sterilizing surgical material
EP0353910A3 (en) Human interferon-gamma, process for preparing said human interferon-gamma, and its use
DE69131058D1 (en) Use of a therapeutic composition for the treatment of bronchitis
DE59410340D1 (en) Use of bradykinin antagonists to treat viral diseases
DK120892D0 (en) TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, FUNGI OR BACTERIA
DE60114876D1 (en) DECONTAMINATION OF PRION-CONTAINING (e.g., BSE-AGENS-CONTAINING) ANIMAL FEED
ATE175959T1 (en) METHOD FOR PRODUCING AZAPHENOTHIAZINES
DE3467341D1 (en) Cyclohexane carboxylic acids and derivatives thereof as antidysrhythmic agents
UA11751A1 (en) Method for heat treatment of articles
ATE101318T1 (en) AQUEOUS SOLUTION FOR OXIDATION, SANITIZATION AND DEODORIZATION AND PROCESS FOR PREPARING SUCH SOLUTION.

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees